Avista Capital Partners, a New York-based healthcare private equity firm, has held the final closing of Avista Capital Partners V, which was over-subscribed, hit its hard-cap and substantially exceeded its target of USD775 million, closing with committed capital of USD1.2 billion.
Thompson Dean and David Burgstahler, Managing Partners and Co-Chief Executive Officers at Avista, says: “The strong closing of the Fund is an endorsement of our investment strategy, underpinned by many years of dedicated healthcare experience, the strength of our investment team, strong alignment of interest with our investors and Avista’s ability to generate consistent returns.”
In deploying the Fund, Avista will continue to invest in leading middle-market healthcare companies where it can drive growth and build lasting value. The Firm’s deep industry expertise, proactive value-added capabilities and partnership-based engagement with portfolio companies has generated significant value through various economic cycles, as demonstrated by its track record.
Read more at Private Equity Wire
